These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8345544)

  • 41. Development of resistance by Plasmodium falciparum to sulfadoxine/pyrimethamine in Amhara Region, Northwestern Ethiopia.
    Kassa M; Sileshi M; Mohammed H; Taye G; Asfaw M
    Ethiop Med J; 2005 Jul; 43(3):181-7. PubMed ID: 16370550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The therapeutic efficacy of sulfadoxine/pyrimethamine against Plasmodium falciparum in Yemen.
    Al-Kabsi AM; Al-Shamahy HA; Al-Harazy AH; Harmal NS
    Med Princ Pract; 2009; 18(1):62-6. PubMed ID: 19060494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine.
    Checchi F; Roddy P; Kamara S; Williams A; Morineau G; Wurie AR; Hora B; Lamotte Nd; Baerwaldt T; Heinzelmann A; Danks A; Pinoges L; Oloo A; Durand R; Ranford-Cartwright L; Smet M;
    Trop Med Int Health; 2005 Feb; 10(2):146-53. PubMed ID: 15679557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
    Spencer HC; Watkins WM; Sixsmith DG; Koech DK; Chulay JD
    Bull World Health Organ; 1984; 62(4):615-21. PubMed ID: 6386209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Plasmodium falciparum drug resistance in the Congo. Evaluation of surveys carried out from 1985 to 1989].
    Carme B; Moudzeo H; Mbitsi A; Sathounkazi C; Ndounga M; Brandicourt O; Gay F; Le Bras J; Gentilini M
    Bull Soc Pathol Exot; 1990; 83(2):228-41. PubMed ID: 2208453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy of the amodiaquine+sulfadoxine-pyrimethamine combination and of chloroquine for the treatment of malaria in Córdoba, Colombia, 2006].
    Pérez MA; Cortés LJ; Guerra AP; Knudson A; Usta C; Nicholls RS
    Biomedica; 2008 Mar; 28(1):148-59. PubMed ID: 18645670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G; Vlahos J; Kamya MR; Staedke SG; Rosenthal PJ
    J Infect Dis; 2003 Oct; 188(8):1231-8. PubMed ID: 14551894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo response of multi-resistant Plasmodium falciparum infections to mefloquine and its combination with sulfadoxine/pyrimethamine in Cambodia.
    Denis MB; Kouznetsov RL; Giboda M
    Folia Parasitol (Praha); 1991; 38(2):187-8. PubMed ID: 1937278
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan.
    Stivanello E; Cavailler P; Cassano F; Omar SA; Kariuki D; Mwangi J; Piola P; Guthmann JP
    Trop Med Int Health; 2004 Sep; 9(9):975-80. PubMed ID: 15361110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacoresistance of Plasmodium falciparum in Rwanda: an in vivo study].
    Gascon J; Soldevila M; Merlos A; Bada JL
    Biomed Pharmacother; 1987; 41(5):250-3. PubMed ID: 3311192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimalarial drug response of Plasmodium falciparum from Zaria, Nigeria.
    Adagu IS; Warhurst DC; Ogala WN; Abdu-Aguye I; Audu LI; Bamgbola FO; Ovwigho UB
    Trans R Soc Trop Med Hyg; 1995; 89(4):422-5. PubMed ID: 7570886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J; Mwankusye S; Mduma S; Veiga MI; Kitua A; Tomson G; Petzold MG; Swedberg G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):137-42. PubMed ID: 18082233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic efficacy of sulfadoxine-pyrimethamine and amodiaquine among children with uncomplicated Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Lemnge MM; Ali AS; Malecela EK; Sambu E; Abdulla R; Juma MS; Fakih K; Abdulla KH; Njau RJ
    Am J Trop Med Hyg; 2005 Oct; 73(4):681-5. PubMed ID: 16222009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Resistance of Plasmodium falciparum to antimalarial drugs in Equatorial Guinea.
    Roche J; Benito A; Ayecaba S; Amela C; Molina R; Alvar J
    Ann Trop Med Parasitol; 1993 Oct; 87(5):443-9. PubMed ID: 8311568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan.
    Nour BY; Faragalla IA; Saeed OK; Mohamadani AA
    Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Status of the response of Plasmodium falciparum to chloroquine and mefloquine in Iran.
    Edrissian GH
    Trop Geogr Med; 1989 Oct; 41(4):297-303. PubMed ID: 2699684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.